Please assess the completion status of the following clinical trial:

Trial Title: Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patient is admitted to the trauma service.~* The patient has a hemothorax and/or or hemopneumothorax, requiring thoracostomy tube placement.~* Thoracostomy tube placement is able to be performed or witnessed by an investigator listed on the study.~* The patient has not had a chest tube in the past year.~* The patient is \>18 years of age.~* In the event the patient is decisionally impaired, consent will be obtained from the individual's legally authorized representative (LAR) or from the individual's healthcare power of attorney (HPA).~* In the instance of reversible impairment, initial consent would be obtained from the LAR/HPA and the patient will be approached for consent once he/she is deemed mentally competent by the care provider.~Exclusion Criteria:~* The patient is incarcerated~* The patient is known to be pregnant~* The patient is \< 18 years of age~* The patient is hemodynamically unstable, requiring emergent chest tube placement (in \<10 minutes from evaluation).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 28 French chest tube for hemothorax (Type: EXPERIMENTAL): 28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
- 14 French chest tube for hemothorax (Type: EXPERIMENTAL): 14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax

Based on this trial design, predict the completion outcome and termination type (if applicable).